N-(5-Carbamoyl-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)phenyl)-4-fluorobenzamide

ID: ALA3612124

Chembl Id: CHEMBL3612124

PubChem CID: 122187959

Max Phase: Preclinical

Molecular Formula: C26H19FN4O4

Molecular Weight: 470.46

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NC(=O)c1ccc(NC(=O)c2ccc(-n3ccccc3=O)cc2)c(NC(=O)c2ccc(F)cc2)c1

Standard InChI:  InChI=1S/C26H19FN4O4/c27-19-9-4-16(5-10-19)26(35)30-22-15-18(24(28)33)8-13-21(22)29-25(34)17-6-11-20(12-7-17)31-14-2-1-3-23(31)32/h1-15H,(H2,28,33)(H,29,34)(H,30,35)

Standard InChI Key:  ULARISHMMGRAJY-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3612124

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 470.46

Molecular Weight (Monoisotopic): 470.1390

AlogP: 3.58

#Rotatable Bonds: 6

Polar Surface Area: 123.29

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.83

CX Basic pKa: ┄

CX LogP: 3.08

CX LogD: 3.08

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.40

Np Likeness Score: -1.46

References

1. Yang J, Su G, Ren Y, Chen Y..  (2015)  Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors.,  101  [PMID:26114810] [10.1016/j.ejmech.2015.06.012]

Source

Source(1):

• Scientific Literature